Nadezhda Glezeva

1.2k total citations
23 papers, 901 citations indexed

About

Nadezhda Glezeva is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Nadezhda Glezeva has authored 23 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Nadezhda Glezeva's work include Heart Failure Treatment and Management (9 papers), Cardiac Fibrosis and Remodeling (7 papers) and Cardiovascular Function and Risk Factors (5 papers). Nadezhda Glezeva is often cited by papers focused on Heart Failure Treatment and Management (9 papers), Cardiac Fibrosis and Remodeling (7 papers) and Cardiovascular Function and Risk Factors (5 papers). Nadezhda Glezeva collaborates with scholars based in Ireland, United Kingdom and United States. Nadezhda Glezeva's co-authors include John A. Baugh, Chris Watson, Mark Ledwidge, Kenneth McDonald, Stephen Horgan, J. Gallagher, Victor Voon, Eoin O’Connell, Courtney Watson and Sabrina Thum and has published in prestigious journals such as Scientific Reports, European Journal of Immunology and Heart.

In The Last Decade

Nadezhda Glezeva

23 papers receiving 891 citations

Peers

Nadezhda Glezeva
Nadezhda Glezeva
Citations per year, relative to Nadezhda Glezeva Nadezhda Glezeva (= 1×) peers Przemysław Leszek

Countries citing papers authored by Nadezhda Glezeva

Since Specialization
Citations

This map shows the geographic impact of Nadezhda Glezeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadezhda Glezeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadezhda Glezeva more than expected).

Fields of papers citing papers by Nadezhda Glezeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadezhda Glezeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadezhda Glezeva. The network helps show where Nadezhda Glezeva may publish in the future.

Co-authorship network of co-authors of Nadezhda Glezeva

This figure shows the co-authorship network connecting the top 25 collaborators of Nadezhda Glezeva. A scholar is included among the top collaborators of Nadezhda Glezeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadezhda Glezeva. Nadezhda Glezeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tonry, Claire, Mark Ledwidge, Nadezhda Glezeva, et al.. (2025). Proteomic-based biomarker discovery reveals panels of diagnostic biomarkers for early identification of heart failure subtypes. Journal of Translational Medicine. 23(1). 546–546. 3 indexed citations
2.
Edgar, Kevin J., Adam Russell‐Hallinan, Nadezhda Glezeva, et al.. (2024). Integrin Beta-Like 1 is Regulated by DNA Methylation and Increased in Heart Failure Patients. ESC Heart Failure. 12(1). 150–165. 2 indexed citations
3.
Russell‐Hallinan, Adam, Claire Tonry, Kevin Edgar, et al.. (2024). Single-Cell RNA Sequencing Reveals Cardiac Fibroblast-Specific Transcriptomic Changes in Dilated Cardiomyopathy. Cells. 13(9). 752–752. 8 indexed citations
4.
Tonry, Claire, Kenneth McDonald, Mark Ledwidge, et al.. (2021). Multiplexed Measurement of Candidate Blood Protein Biomarkers of Heart Failure. ESC Heart Failure. 8(3). 2248–2258. 9 indexed citations
5.
Humphries, Fiachra, Bingwei Wang, Ashling Holland, et al.. (2021). ECSIT is a critical limiting factor for cardiac function. JCI Insight. 6(12). 13 indexed citations
6.
Gallagher, J., Sudipto Das, Richard J. Drew, et al.. (2021). Aetiology and severity of childhood pneumonia in primary care in Malawi: a cohort study. BMJ Open. 11(7). e046633–e046633. 7 indexed citations
7.
McDonald, Kenneth, Nadezhda Glezeva, Patrick Collier, et al.. (2020). Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis. Scientific Reports. 10(1). 7507–7507. 19 indexed citations
8.
Watson, Chris, Nadezhda Glezeva, Stephen Horgan, et al.. (2020). Atrial Tissue Pro‐Fibrotic M2 Macrophage Marker CD163+, Gene Expression of Procollagen and B‐Type Natriuretic Peptide. Journal of the American Heart Association. 9(11). e013416–e013416. 28 indexed citations
9.
Watson, Chris, Isaac Tea, Eoin O’Connell, et al.. (2020). Comparison of longitudinal change in sST2 vs BNP to predict major adverse cardiovascular events in asymptomatic patients in the community. Journal of Cellular and Molecular Medicine. 24(11). 6495–6499. 7 indexed citations
10.
Glezeva, Nadezhda, et al.. (2017). Diabetes and complications of the heart in Sub-Saharan Africa: An urgent need for improved awareness, diagnostics and management. Diabetes Research and Clinical Practice. 137. 10–19. 25 indexed citations
11.
Glezeva, Nadezhda, Stephen Horgan, & John A. Baugh. (2015). Monocyte and macrophage subsets along the continuum to heart failure: Misguided heroes or targetable villains?. Journal of Molecular and Cellular Cardiology. 89(Pt B). 136–145. 51 indexed citations
12.
Watson, Chris, Shashi Kumar Gupta, Eoin O’Connell, et al.. (2015). MicroRNA Signatures Differentiate Preserved from Reduced Ejection Fraction Heart Failure. European Journal of Heart Failure. 17(4). 405–415. 161 indexed citations
13.
Glezeva, Nadezhda, John F. Gilmer, Chris Watson, & Mark Ledwidge. (2015). A Central Role for Monocyte–Platelet Interactions in Heart Failure. Journal of Cardiovascular Pharmacology and Therapeutics. 21(3). 245–261. 23 indexed citations
14.
Watson, Chris, Stephen Horgan, Roisín Neary, et al.. (2015). Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis. Journal of Cardiovascular Pharmacology and Therapeutics. 21(1). 127–137. 74 indexed citations
15.
Glezeva, Nadezhda, Victor Voon, Chris Watson, et al.. (2014). Exaggerated Inflammation and Monocytosis Associate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction: Evidence of M2 Macrophage Activation in Disease Pathogenesis. Journal of Cardiac Failure. 21(2). 167–177. 122 indexed citations
16.
Horgan, Stephen, Courtney Watson, Nadezhda Glezeva, & John A. Baugh. (2014). Murine Models of Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction. Journal of Cardiac Failure. 20(12). 984–995. 66 indexed citations
17.
Glezeva, Nadezhda, Patrick Collier, Victor Voon, et al.. (2013). Attenuation of Monocyte Chemotaxis—A Novel Anti-inflammatory Mechanism of Action for the Cardio-protective Hormone B-Type Natriuretic Peptide. Journal of Cardiovascular Translational Research. 6(4). 545–557. 24 indexed citations
18.
Glezeva, Nadezhda & John A. Baugh. (2013). Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart Failure Reviews. 19(5). 681–694. 148 indexed citations
19.
Glezeva, Nadezhda, Patrick Collier, Chris Watson, et al.. (2012). INCREASED INFLAMMATORY AND ALTERNATIVE MONOCYTE/MACROPHAGE MARKERS IN PATIENTS WITH HYPERTENSION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION. Heart. 98(Suppl 5). A6.3–A7. 1 indexed citations
20.
Bendix, Ivo, Caspar F. Pfueller, Tina Leuenberger, et al.. (2010). MAPK3 deficiency drives autoimmunity via DC arming. European Journal of Immunology. 40(5). 1486–1495. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026